4,176 Shares in HCA Healthcare, Inc. $HCA Acquired by Canandaigua National Bank & Trust Co.

Canandaigua National Bank & Trust Co. acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the 2nd quarter, Holdings Channel.com reports. The fund acquired 4,176 shares of the company’s stock, valued at approximately $1,628,000.

Several other hedge funds also recently added to or reduced their stakes in the business. Palisade Asset Management LLC acquired a new position in HCA Healthcare in the 3rd quarter worth about $26,000. Ares Financial Consulting LLC acquired a new stake in HCA Healthcare in the 4th quarter valued at about $31,000. Cedar Mountain Advisors LLC purchased a new stake in shares of HCA Healthcare during the 1st quarter valued at approximately $33,000. JPL Wealth Management LLC purchased a new position in HCA Healthcare during the third quarter worth about $33,000. Finally, MCF Advisors LLC lifted its position in shares of HCA Healthcare by 213.0% during the fourth quarter. MCF Advisors LLC now owns 72 shares of the company’s stock worth $34,000 after purchasing an additional 49 shares in the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on the stock. TD Cowen reduced their target price on shares of HCA Healthcare from $500.00 to $431.00 and set a “buy” rating on the stock in a report on Monday, June 22nd. Robert W. Baird cut their price target on HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating on the stock in a report on Monday, July 27th. UBS Group lowered their price objective on HCA Healthcare from $635.00 to $579.00 and set a “buy” rating for the company in a research report on Monday, July 27th. Wells Fargo & Company lifted their price target on shares of HCA Healthcare from $369.00 to $381.00 and gave the stock an “equal weight” rating in a research note on Monday. Finally, The Goldman Sachs Group reduced their price objective on shares of HCA Healthcare from $558.00 to $485.00 and set a “buy” rating on the stock in a report on Tuesday, July 28th. Fourteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $465.59.

HCA Healthcare Stock Up 2.3%

HCA opened at $409.78 on Thursday. The firm has a market cap of $88.72 billion, a price-to-earnings ratio of 13.72, a price-to-earnings-growth ratio of 1.39 and a beta of 1.10. The business’s 50 day moving average is $387.79 and its two-hundred day moving average is $449.42. HCA Healthcare, Inc. has a 52 week low of $353.99 and a 52 week high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share for the quarter, topping the consensus estimate of $7.56 by $0.03. The firm had revenue of $20.23 billion during the quarter, compared to the consensus estimate of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The company’s revenue for the quarter was up 8.7% on a year-over-year basis. During the same period last year, the company earned $6.84 earnings per share. Equities analysts expect that HCA Healthcare, Inc. will post 29.45 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Investors of record on Wednesday, September 16th will be paid a $0.78 dividend. This represents a $3.12 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.45%.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Wells Fargo analyst commentary indicated that HCA Healthcare’s stock is expected to rise, reinforcing a favorable Wall Street view of the company’s outlook. HCA Healthcare Stock Price Expected to Rise, Wells Fargo Analyst Says
• Positive Sentiment: HCA Healthcare acquired 40 Texas urgent-care centers from Texas MedClinic, expanding its outpatient footprint and adding facilities in a growing, lower-cost segment of healthcare delivery. The clinics are being rebranded under HCA’s network, which could support referral growth and operating synergies. HCA Acquires 40 Texas Urgent Care Centers
• Neutral Sentiment: An independent monitor discussed HCA’s ownership of Mission Hospital. The report keeps attention on oversight and performance at the North Carolina facility, but the article does not indicate a new financial penalty or material change to HCA’s operations. Independent Monitor Discusses HCA’s Ownership of Mission Hospital
• Negative Sentiment: Several law firms announced investigations into HCA and possible securities-law violations following the company’s preliminary operating and financial disclosures. These notices are generally solicitations for investors and do not establish wrongdoing, but they add headline risk and could lead to litigation costs or additional scrutiny. HCA Shareholder Alert Pomerantz Investor Alert Bragar Eagel & Squire Investigation Alert

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.